Thomas Illig
University of Bonn
8 Papers
40 Citations
Thomas Illig is an academic researcher from University of Bonn. The author has contributed to research in topics: Gene & Chemokine. The author has an hindex of 5, co-authored 8 publications.
Chat about Author
Papers
No association between the serine racemase gene (SRR) and schizophrenia in a German case-control sample.
Jana Strohmaier,Alexander Georgi,Frederike Schirmbeck,Christine Schmael,Rami Abou Jamra,Johannes Schumacher,Tim Becker,Susanne Höfels,N. Klopp,Thomas Illig,Peter Propping,Sven Cichon,Markus M. Nöthen,Marcella Rietschel,Thomas G. Schulze +14 more
TL;DR: Division of Genetic Epidemiology, Central Institute of Mental Health, Mannheim,Institute of Human Genetics, Institute of Medical Biometry, Informatics, and epidemiology, Departments of Psychiatry, GSF, Ingolstädter Neuherberg and Genomics, Life & Brain Center, University of Bonn, Bonn.
13
Compléments : Genetic variation in the Toll-like receptor signaling pathway is associated with childhood asthma
Ramesh Chandra Pandey,Sven Michel,Riccardina Tesse,Aristea Binia,Michaela Schedel,Liming Liang,N. Klopp,Andre Franke,Andrea von Berg,Albrecht Bufe,Ernst Rietschel,Andrea Heinzmann,Otto Laub,Burkhard Simma,Thomas Frischer,Jon Genuneit,Thomas Illig,Michael Kabesch +17 more
- 30 Jan 2013
9
No evidence for an association between variants at the gamma-amino-n-butyric acid type A receptor beta2 locus and schizophrenia.
Rami Abou Jamra,Tim Becker,Norman Klopp,Faten Dahdouh,Thomas G. Schulze,Magdalena Gross,Monika Deschner,Christine Schmäl,Thomas Illig,Marcella Rietschel,Peter Propping,Sven Cichon,Markus M. Nöthen,Johannes Schumacher +13 more
TL;DR: The results do not support the hypothesis that genetic variation at the GABRB2 locus plays a major role in schizophrenic patients of European descent and that such variation would explain the previously observed linkage findings at this chromosomal region.
9
Patent
Biomarkers for type 2 diabetes
Wolfgang Rathmann,Christian Herder,Thomas Illig,Jerzy Adamski,Rui Wang-Sattler,Zhongao Yu,H.-Erich Wichmann,Hans-Ulrich Häring,Annette Peters,Christine Meisinger,DE Angelis Martin Hrabé,Michael Roden,Thomas Meitinger +12 more
- 13 Aug 2013
TL;DR: In this paper, a method of identifying a predisposition for developing type 2 diabetes mellitus in a subject was proposed, which consisted the step of assessing in a sample obtained from said subject the amount of one or more metabolite(s) selected from (a) a first group comprising the metabolites glycine, lysoPhosphatidylcholine acyl C18:2, and (b) a second group consisting the metabolite acetylcarnitine C2 and an isobaric metabolite having the same molecular mass as glycine but different chemical
8
other inflammatory mediators circulating concentrations of monocyte chemoattractant protein-1 and Duffy antigen receptor for chemokines (Darc) polymorphism regulates
Wolfgang Koenig,Russell P. Tracy,Christie M. Ballantyne,Jacqueline C. M. Witteman,Ron C. Hoogeveen,Emelia J. Benjamin,Ramachandran S. Vasan,N. Klopp,Eric Boerwinkle,Martin G. Larson,Bruce M. Psaty,Stefan Blankenberg,C. Herder,Jeremy D. Walston,Christian Gieger,Cathy Tilley,Jennifer F. Yamamoto,Natalie Khuseyinova,Gerardo Heiss,Abbas Dehghan,Joshua C. Bis,Thomas Illig,Alanna C. Morrison,Nancy S. Jenny,John F. Keaney,Renate B. Schnabel,Jens Baumert,Maja Barbalić,Josée Dupuis,Patrick T. Ellinor,Peter Durda +30 more
- 01 Jan 2014
1